MIM
AMAM
Monashee Investment Management’s Ambrx Biopharma, Inc. Common Stock AMAM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-207,500
| Closed | -$2.95M | – | 124 |
|
|
2023
Q4 | $2.95M | Buy |
207,500
+137,500
| +196% | +$1.96M | 0.52% | 19 |
|
|
2023
Q3 | $805K | Buy |
+70,000
| New | +$805K | 0.34% | 63 |
|
|
2021
Q3 | – | Sell |
-110,000
| Closed | -$2.16M | – | 402 |
|
|
2021
Q2 | $2.16M | Buy |
+110,000
| New | +$2.16M | 0.26% | 111 |
|